title: Impact of blood transfusions and HLA matching on national kidney transplant programs: the first Swedish-Norwegian Study of cyclosporine.
authors.affiliation: National Hospital, Oslo, Norway.
authors.forename: D
authors.initials: D
authors.lastname: Albrechtsen
authors.forename: A
authors.initials: A
authors.lastname: Flatmark
authors.forename: H
authors.initials: H
authors.lastname: Brynger
authors.forename: L
authors.initials: L
authors.lastname: Frödin
authors.forename: H
authors.initials: H
authors.lastname: Gäbel
authors.forename: C G
authors.initials: CG
authors.lastname: Groth
authors.forename: G
authors.initials: G
authors.lastname: Lundgren
authors.forename: W
authors.initials: W
authors.lastname: Maurer
mesh_terms: D001803:Blood Transfusion; D002102:Cadaver; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006681:HLA-D Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006239:Haplotypes; D006648:Histocompatibility; D006801:Humans; D016030:Kidney Transplantation; D012008:Recurrence
chemical_list: D006680:HLA Antigens; D006681:HLA-D Antigens; D006684:HLA-DR Antigens